Last updated on February 2018

Combination of Lenalidomide and Dexamethasone in Treatment of Multiple Myeloma


Brief description of study

In this study for elderly myeloma patients lenalidomide plus low-dose dexamethasone until progression is being compared with age-adjusted tandem high-dose melphalan 140 mg/m augmented by induction with 3 cycles of lenalidomide plus low-dose dexamethasone before transplantation and lenalidomide maintenance after transplantation.

Clinical Study Identifier: NCT01090089

Find a site near you

Start Over

Klinikum Nord

Nürnberg, Germany
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.